Richard Armstrong retweeted
I find it amazing that all of the people citing ‘hearsay’ as a reason to discount evidence against Brand, think they have a more acute legal mind than Brand’s defence team, whom at no point raised this themselves.
#RussellBrand #rapist
Richard Armstrong retweeted
Witkoff and Kushner. Two unelected pieces of shit with no democratic mandate, sitting down with a war criminal as though they have the authority to negotiate. This should fucking enrage everyone.
Richard Armstrong retweeted
“ I am today resigning as Microsoft’s head of international outage protection”
Here’s a man who knows he will soon be employed by Big Pharma - and also knows his commute won’t change !
#AVCT
Richard Armstrong retweeted
#AVCT
I agree, Tom & Benny.
Long-term investors have funded the scientific progress, but I also think we’re at a tipping point where the AVA6103 data will be compelling and put us even more firmly on pharma companies’ radar. We are entering the cannot be ignored disrupt zone.
Small biotech companies like Avacta, with potentially groundbreaking science, should be protected and nurtured. Shorting small pharma and life science companies should, IMO, be banned. I regard it as an abhorrent form of sabotage.
Regardless of my investment in Avacta, I would still think TW et al are scumbags.
You were told. Seen this fleecing too many times before. So many geared shareholders taken out just as #AVCT’s second drug is in its golden efficacy zone.
Amazing how gullible some people can be. Fear & greed are powerful tools when the Market Makers use them against you. Avacta is off to the stars.
AVA6103 ‘sure bet’ as per the CEO. Think about the magnitude of that statement.
It will equate into a Biblical bounce
This is the greatest gift that #avct investors or (dare I say it) traders will ever see.
On the Daily chart the RSI is down to 19.7 - last time it hit this level the stock bounced 50% in no time.
Bookmark this tweet - this time will be no different
Richard Armstrong retweeted
The man who invented Benylin was buried last week.
As a mark of respect there was no coffin at his funeral.
Happy to report that after day after day of huge shapes in the auctions the uncrossing trade was at 54p on volume of 18,647 shares
SHENANIGANS complete
52p was the low today
Any bets on the pre Christmas-high? #avct #firsttimeinalongtime #Trendreversal
Richard Armstrong retweeted
As I digest the millionth opinion on #AVCT I am reminded (Stanley Druckenmiller) the best way to make obscene amounts of money is buying an idea which is not popular today but what will be popular tomorrow.
AVA6103 is the on cusp of that revolution.
Churning out data - right now - which will define how toxic chemotherapies are delivered safely tomorrow.
I don’t think even the staunchest advocates realise the magnitude of what AVCT is sat on right now in AVA6103:
“A remarkable alignment of pre-clinical and clinical data”
“The best (Coughlin) has seen in over two decades”
A “sure bet”.
It works. Enormous value is inevitable if you can detach from the artificial noise.
Every single time the mass trolling and FUD stops with #Avct you know that a reversal is coming.
As predictable as night follows day - and all (like the last times) totally orchestrated.
The Directors happily paid up for a million shares at 68p - at this level here's your Christmas present. So much to be announced in the next weeks.
And never forget - the data which is rolling right now will dictate the value of ALL the deals on the table.
Richard Armstrong retweeted
I reckon Guy Fawkes plan to blow up Parliament on November 5th was kind of genius because people wouldn't notice the explosions, what with all the fireworks going off & all.
This is the greatest gift that #avct investors or (dare I say it) traders will ever see.
On the Daily chart the RSI is down to 19.7 - last time it hit this level the stock bounced 50% in no time.
Bookmark this tweet - this time will be no different
Richard Armstrong retweeted
🚨Cheshire East Council just painted poppies on the roads to honour our fallen.
Meanwhile half the country’s councils are busy erasing history, renaming streets, and lecturing everyone about ‘diversity’.
One council still remembers who built and defended this country.
The rest are busy apologising for it.
Richard Armstrong retweeted
Guy behind me at the traffic lights, beeping your horn and giving me the wanker sign isn’t going to make me type this tweet any faster.
Myles absolutely hitting all the nails on the head here ........#AVCT
Regardless of whether it was a determined seller or a short that has dragged #AVCT down in recent weeks, I think these numerous big prints at 55/56p mark the bottom of this mad selloff.
I'm sure very many are watching closely (like me!) for any further big prints today, and are beginning to scale (more) in for a strong recovery from the current 9-month low share price.
We had a £12m cash injection at a (then) discounted 68p less than 4 weeks ago. Cash runway extends to May next year, and gross debt is now a negligible <£10m.
We're highly likely to see some form of partnership for the first Gen3 asset, AVA6207, before Christmas (given the ATRi reveal in 14 days' time); as well as another form of partnership for AVA6000 - in my view again before Christmas - to fund it through the pivotal Phase 2 trial.
Do they partner 6103 this early on? I would hope not, unless it's for a very narrow scope (a single indication in a single region) and for a monster upfront cash sum ($100m+).
Despite what the SP currently portrays, Avacta continues to make gargantuan strides. But we continue to suffer from a surreal blend of PTSD (caused by dramatic volatility over the past six years), and a case of a too-good-to-be-true story. And, of course, overleveraged players getting spanked every few months by the aforementioned volatility!
Ignore the noise and volatility, and appreciate that Avacta is doing remarkanble work in the battle against cancer.
A multi-billion-$ for shareholders is, in my eyes, more likely than ever before.
Market is acting like #AVCT is funded into December 2026, rather than May 2027.
A lot can happen in a very short time in biotech.
And Avacta has x5 shots on goal:
AVA6000 (SGC)
AVA6000 (TNBC)
AVA6103 (multiple shots)
AVA6207 (also multiple shots)
PRECISION (to a 3rd party warhead)
Never been more confident - today buying Avacta is the cheapest and safest that it has ever been.
So I did !



















